The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
15-Deoxy-Δ12,14-prostaglandin J2Inhibition of NF-κB-DNA Binding through Covalent Modification of the p50 Subunit
Open accessAbstract
Cyclopentenone prostaglandins display anti-inflammatory activities and interfere with the signaling pathway that leads to activation of transcription factor NF-kappaB. Here we explore the possibility that the NF-kappaB subunit p50 may be a target for the cyclopentenone 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)). This prostaglandin inhibited the DNA binding ability of recombinant p50 in a dose-dependent manner. The inhibition required the cyclopentenone moiety and could be prevented but not reverted by glutathione and dithiothreitol. Moreover, a p50 mutant with a C62S mutation was resistant to inhibition, indicating that the effect of 15d-PGJ(2) was probably due to its interaction with cysteine 62 in p50. The covalent modification of p50 by 15d-PGJ(2) was demonstrated by reverse-phase high pressure liquid chromatography and mass spectrometry analysis that showed an increase in retention time and in the molecular mass of 15d-PGJ(2)-treated p50, respectively. The interaction between p50 and 15d-PGJ(2) was relevant in intact cells. 15d-PGJ(2) effectively inhibited cytokine-elicited NF-kappaB activity in HeLa without reducing IkappaBalpha degradation or nuclear translocation of NF-kappaB subunits. 15d-PGJ(2) reduced NF-kappaB DNA binding activity in isolated nuclear extracts, suggesting a direct effect on NF-kappaB proteins. Finally, treatment of HeLa with biotinylated-15d-PGJ(2) resulted in the formation of a 15d-PGJ(2)-p50 adduct as demonstrated by neutravidin binding and immunoprecipitation. These results clearly show that p50 is a target for covalent modification by 15d-PGJ(2) that results in inhibition of DNA binding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P., & Ghosh, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80222-6 · Cited by 827
Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb
Janssen-Heininger, Y. M. W., Poynter, M. E., & Baeuerle, P. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00218-5 · Cited by 666
Crofford, L. J., Wilder, R. L., Ristimäki, A. P., Sano, H., Remmers, E. F., Epps, H. R., & Hla, T. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117060 · Cited by 655
NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.
Baeuerle, P. A., & Baichwal, V. R. (1997) · PubMed · Cited by 615
Sizemore, N., Leung, S., & Stark, G. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4798 · Cited by 557
Baeuerle, P. A., & Baichwal, V. R. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60742-7 · Cited by 511
Inhibition of NF- B DNA Binding by Nitric Oxide
Matthews, J. R., Botting, C. H., Panico, M., Morris, H. R., & Hay, R. T. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.12.2236 · Cited by 495
Li, M., Pascual, G., & Glass, C. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4699-4707.2000 · Cited by 377
Petrova, T. V., Akama, K. T., & Van Eldik, L. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4668 · Cited by 314
Pro-inflammatory signaling: Last pieces in the NF-κB puzzle?
Baeuerle, P. A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70010-7 · Cited by 277
Feedback control of cyclooxygenase-2 expression through PPARγ
Inoue, H., Tanabe, T., & Umesono, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001387200 · Cited by 276
Castrillo, A., Díaz-Guerra, M. J. M., Hortelano, S., Martín-Sanz, P., & Boscá, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1692-1698.2000 · Cited by 264
Mihm, S., Galter, D., & Dröge, W. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781927 · Cited by 164
Formation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway
Chen, Y., Morrow, J. D., & Roberts, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10863 · Cited by 155
Induction of Cyclo-Oxygenase and Nitric Oxide Synthase in Inflammation
Appleton, I., Tomlinson, A., & Willoughby, D. A. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60274-4 · Cited by 144
Narumiya, S., Ohno, K., Fukushima, M., & Fujiwara, M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39070-1 · Cited by 138
Tolédano, M. B., Ghosh, D., Trinh, F., & Leonard, W. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.852 · Cited by 126
Hortelano, S., Castrillo, A., Alvarez, A. M., & Boscá, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6525 · Cited by 117
Atsmon, J., Freeman, M. L., Meredith, M. J., Sweetman, B. J., & Roberts, L. J. (1990) · PubMed · Cited by 90
Atsmon, J., Sweetman, B. J., Baertschi, S. W., Harris, T. M., & Roberts, L. J. (1990) · Biochemistry · doi:10.1021/bi00467a023 · Cited by 88
Prostaglandin A2 and Δ12‐prostaglandin J2 induce apoptosis in L1210 cells
Kim, I., Lee, J. H., Sohn, H., Kim, H., & Kim, S.-H. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80110-g · Cited by 87
Klatt, P., Pineda‐Molina, E., Pérez‐Sala, D., & Lamas, S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490567 · Cited by 86
Self-citationMacKichan, M. L., Logeat, F., & Israël, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6084 · Cited by 77
Martín, Á. G., & Fresno, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909396199 · Cited by 69
Dual Effect of Nitric Oxide Donors on Cyclooxygenase-2 Expression in Human Mesangial Cells
Díaz-Cazorla, M., Pérez‐Sala, D., & Lamas, S. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v105943 · Cited by 68
Self-citationPhosphorylation of NF-KB1-p50 is involved in NF-kappa B activation and stable DNA binding.
Li, C. C., Dai, R. M., Chen, E., & Longo, D. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43777-5 · Cited by 65
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Anti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
Inflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Ruiz, S., Pergola, P. E., Zager, R. A., & Vaziri, N. D. (2013) · Kidney International · doi:10.1038/ki.2012.439 · Cited by 718
Metadata
- Authors
- Cernuda-Morollón, E., Pineda-Molina, E., Cañada, F. J., & Pérez-Sala, D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 276
- Issue
- 38
- Pages
- 35530-35536
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2064208521
- Cited by
- 292
- References
- 37
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.